By Lizzie Mooney
Measuring and tracking unnecessary or repetitive testing can be a daunting task for any healthcare organization, especially as keeping current with uncertain government regulations presents challenges of its own. While the future of the Affordable Care Act may be foggy, one thing that’s clear is that today’s “volume to value” transition is here to stay, and that makes reining in test utilization and costs an essential priority.
Subscribe to the blog
Previous Post Novaseek Research and hc1.com® Announce Partnership to Expand Offerings to Clinical Laboratories for Improved Performance and Increased Revenue
Next Post hc1.com #1 Healthcare CRM Rated By Users; Exceeds Adoption at 1,100 Client Sites